STOCK TITAN

TRIO-TECH (TRT) director exercises 70K options and sells 10K common shares

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

TRIO-TECH INTERNATIONAL director Jason T. Adelman reported option exercises and share sales. On June 23, 2026, he exercised derivative securities to acquire 70,000 shares of Common Stock at an exercise price of $3.11 per share, increasing his direct holdings.

Before that, he completed open-market sales of 5,000 shares at $15.84 per share on June 18, 2026 and 5,000 shares at $14.88 per share on June 19, 2026, for total sales of 10,000 shares. Following these transactions, he directly owns 210,094 shares of Common Stock, and the exercised derivative position is fully converted with no remaining derivative holdings reported.

Positive

  • None.

Negative

  • None.
Insider ADELMAN JASON T
Role null
Sold 10,000 shs ($154K)
Type Security Shares Price Value
Exercise Common Stock (Right to Buy) 70,000 $0.00 --
Exercise Common Stock 70,000 $3.11 $218K
Sale Common Stock 5,000 $14.88 $74K
Sale Common Stock 5,000 $15.84 $79K
Holdings After Transaction: Common Stock (Right to Buy) — 0 shares (Direct, null); Common Stock — 210,094 shares (Direct, null)
Footnotes (1)
Options exercised 70,000 shares Common Stock acquired via derivative exercise on June 23, 2026
Exercise price $3.11 per share Price for exercising “Common Stock (Right to Buy)” derivative
Sale on June 18, 2026 5,000 shares at $15.84 Open-market sale of Common Stock
Sale on June 19, 2026 5,000 shares at $14.88 Open-market sale of Common Stock
Total shares sold 10,000 shares Aggregate open-market sales on June 18–19, 2026
Shares owned after 210,094 shares Direct Common Stock holdings following transactions
Derivative shares remaining 0 shares Common Stock (Right to Buy) position after exercise
Option expiration date March 25, 2030 Original expiration for exercised derivative grant
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
Common Stock (Right to Buy) financial
"security_title": "Common Stock (Right to Buy)""
transaction_code "M" regulatory
"transaction_code": "M""
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
ADELMAN JASON T

(Last)(First)(Middle)
C/O TRIO-TECH INTERNATIONAL
16139 WYANDOTTE ST

(Street)
VAN NUYS CALIFORNIA 91406

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
TRIO-TECH INTERNATIONAL [ TRT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/18/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/18/2026S5,000D$15.84145,094D
Common Stock06/19/2026S5,000D$14.88140,094D
Common Stock06/23/2026M70,000A$3.11210,094D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Common Stock (Right to Buy)$3.1106/23/2026M70,00003/26/202503/25/2030Common Stock70,000$00D
Explanation of Responses:
/s/ Jason Adelman06/23/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did TRT director Jason T. Adelman report?

Jason T. Adelman reported exercising options for 70,000 TRT common shares and selling 10,000 shares. The exercise occurred on June 23, 2026, while the sales took place on June 18 and 19, 2026, in open-market transactions at prices above $14 per share.

How many TRIO-TECH INTERNATIONAL (TRT) shares does Jason T. Adelman hold after these transactions?

After the reported transactions, Jason T. Adelman directly holds 210,094 TRT common shares. This figure reflects both the 70,000-share option exercise on June 23, 2026, and the two open-market sales totaling 10,000 shares executed on June 18 and 19, 2026.

At what prices did Jason T. Adelman sell TRT shares in the open market?

He sold 5,000 TRT common shares at $15.84 per share on June 18, 2026, and another 5,000 shares at $14.88 per share on June 19, 2026. These transactions are classified as open-market or private sales in the Form 4 filing.

What was the exercise price for Jason T. Adelman’s TRT stock options?

The derivative securities labeled “Common Stock (Right to Buy)” were exercised at $3.11 per share. Exercising these rights on June 23, 2026, converted them into 70,000 shares of TRT common stock and reduced the remaining derivative position under that grant to zero.

Did Jason T. Adelman retain any TRT derivative securities after the reported option exercise?

No, the filing shows that after exercising 70,000 “Common Stock (Right to Buy)” derivatives, the total derivative shares following the transaction are zero. This indicates the specific derivative position reported was fully exercised into common stock.